The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...
The Alzheimer's epidemic continues to cast a shadow over the lives of millions of people. With no effective treatment ...
As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...
In a year plagued by the challenges of Alzheimer's disease, 2024 brought a glimmer of hope with the approval of the third new ...
According to Phipps, the drugs currently available to treat Alzheimer’s have only eased the symptoms rather than stop its ...
Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...
Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...
Dec. 19, 2024 — Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, ... Study Supports New Blood ...
The slow uptake could stem in part from a disparity in physician attitudes to the new drugs, with some seeing them as an important new treatment option for Alzheimer's – the first with the ...
Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...
What if the solution to Alzheimer’s disease lies not in combating the proteins that cause it, but in simply getting more ...
Scientists investigating Alzheimer’s disease have made a key breakthrough, identifying a key cellular process that drives ...